The availability of PDE5 inhibitors has significantly altered the way in which erectile dysfunction (ED) is treated. Some major issues have emerged since the advent of PDE5 inhibitor use for ED, especially in relation to recreational use in young, healthy men and the role of confidence in erectile ability.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Althof, S. E. When an erection alone is not enough: biopsychosocial obstacles to lovemaking. Int. J. Impot. Res. 14, S99–104 (2002).
Harte, C. B. & Meston, C. M. Recreational use of erectile dysfunction medications and its adverse effects on erectile function in young healthy men: the mediating role of confidence in erectile ability. J. Sex. Med. 9, 1852–1859 (2012).
Melnik, T., Abdo, C. H., de Moraes, J. F. & Riera, R. Satisfaction with the treatment, confidence and 'naturalness' in engaging in sexual activity in men with psychogenic erectile dysfunction: preliminary results of a randomized controlled trial of three therapeutic approaches. BJU Int. 109, 1213–1219 (2012).
Harte, C. B. & Meston, C. M. Recreational use of erectile dysfunction medications in undergraduate men in the United States: characteristics and associated risk factors. Arch. Sex. Behav. 40, 597–606 (2011).
Korkes, F., Costa-Matos, A., Gasperini, R., Reginato, P. V. & Perez, M. D. C. Recreational use of PDE5 inhibitors by young healthy men: recognizing this issue among medical students. J. Sex. Med. 5, 2414–2418 (2008).
Bechara, A., Casabé, A., De Bonis, W., Helien, A. & Bertolino, M. V. Recreational use of phosphodiesterase type 5 inhibitors by healthy young men. J. Sex. Med. 7, 3736–3742 (2010).
Cachay, E., Mar-Tang, M. & Mathews, W. C. Screening for potentially transmitting sexual risk behaviors, urethral sexually transmitted infection, and sildenafil use among males entering care for HIV infection. AIDS Patient Care STDS 18, 349–354 (2004).
Swearingen, S. G. & Klausner, J. D. Sildenafil use, sexual risk behavior, and risk for sexually transmitted diseases, including HIV infection. Am. J. Med. 118, 571–577 (2005).
Melnik, T., Soares, B. G. & Nasello, A. G. The effectiveness of psychological interventions for the treatment of erectile dysfunction: systematic review and meta-analysis, including comparisons to sildenafil treatment, intracavernosal injection, and vacuum devices. J. Sex. Med. 5, 2562–2574 (2008).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Melnik, T. The psychological effects of recreational PDE5 inhibitor use. Nat Rev Urol 9, 479–480 (2012). https://doi.org/10.1038/nrurol.2012.149
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2012.149
